DAVID DE GONZALO CALVO-rekin lankidetzan egindako argitalpenak (149)

2024

  1. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity

    International Journal of Biological Macromolecules, Vol. 269

  2. Circular RNA regulatory role in pathological cardiac remodelling

    British Journal of Pharmacology

  3. Circulating long noncoding RNA PDE4DIPP6: A novel biomarker for improving the clinical management of non-ST-segment elevation myocardial infarction

    Clinica Chimica Acta, Vol. 561

  4. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  5. Decoding viral and host microRNA signatures in airway-derived biosamples: Insights for biomarker discovery in viral respiratory infections

    Biomedicine and Pharmacotherapy, Vol. 177

  6. Exploring the translational landscape of the long noncoding RNA transcriptome in acute respiratory distress syndrome: it is a long way to the top

    European respiratory review : an official journal of the European Respiratory Society, Vol. 33, Núm. 172

  7. Guidelines for mitochondrial RNA analysis

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 3

  8. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients

    Management, Body Systems, and Case Studies in COVID-19 (Elsevier), pp. 285-294

  9. Machine learning for catalysing the integration of noncoding RNA in research and clinical practice

    eBioMedicine, Vol. 106

  10. MicroRNA-centered theranostics for pulmoprotection in critical COVID-19

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  11. MicroRNA-guided drug discovery for mitigating persistent pulmonary complications in critical COVID-19 survivors: A longitudinal pilot study

    British Journal of Pharmacology

  12. Navigating the path of reproducibility in microRNA-based biomarker research with ring trials

    Clinical Chemistry and Laboratory Medicine

  13. Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 1

  14. Searching for New Biomarkers in Respiratory Medicine: Present and Future of miRNAs

    Archivos de Bronconeumologia

  15. Sleep and Circadian Health of Critical Survivors: A 12-Month Follow-Up Study

    Critical Care Medicine, Vol. 52, Núm. 8, pp. 1206-1217

  16. microRNA Expression Profile in Obesity-Induced Kidney Disease Driven by High-Fat Diet in Mice

    Nutrients, Vol. 16, Núm. 5

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

    Biomedicine and Pharmacotherapy, Vol. 162

  4. Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

    Journal of Translational Medicine, Vol. 21, Núm. 1